1. Home
  2. Live Updates
  3. Moderna inc

Live Breaking News & Updates on Moderna inc

Stay informed with the latest breaking news from Moderna inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Moderna inc and stay connected to the pulse of your community

Moderna receives a $750M infusion from Blackstone

Blackstone Life Sciences made an investment of up to $750 million in Moderna Inc.’s influenza program created with its mRNA technology. The new funding is designed to help propel the program forward and may help bolster a stock that has struggled in the past 12 months.

Blackstone-life-sciences , Moderna-inc , Moderna-inc- , Influenza , Mrna , Bioworld , Financings , Infection , Vaccine , Mrna-1283 , Covid-19

Moderna posts surprise quarterly profit even as COVID sales continue to slide

Moderna on Thursday reported a surprise fourth-quarter profit even as its COVID product sales continue to plunge.

Moderna-spikevax , Stephane-bancel , Centers-for-disease , Drug-administration , Merck-co , Vaccine-alliance , Moderna-inc , Chief-financial-officer-jamey-mock , Executive-stephane-bancel , Disease-control , Article-normal , Biotechnology

Dow poised for fresh record as Nvidia earnings spur stock-market rally

The Dow and S&P 500 aim for record highs as another blowout earnings report from Nvidia lifts technology stocks.

Nasdaq , Nvidia-corp , Nasdaq-composite , Article-normal , Computers-electronics , Environmental-control-systems , Semiconductors , Textiles , Market-research-public-relations , Public-relations , Real-estate-services-transactions

Moderna's stock rises on 2023 product sales of $6.7B

Moderna Inc.’s stock was up by 1.2% after the drug maker said it sold $6.7 billion of products in 2023. Analyst expected the company to sell $6.35 billion in...

Moderna-inc , Article-normal , Pharmaceuticals , Acquisitions-mergers-takeovers , Moderna-inc- , Mrna , Acquisitions , Mergers , Takeovers ,

CureVac stock gains as COVID vaccine candidates show promise

CureVac N.V. shares gained 3% premarket on Friday as the company released new data from a trial of its mRNA COVID-19 vaccine candidates, which it is...

United-states , American , Pfizer-inc , European-union , Moderna-inc , Article-normal , Biotechnology , Curevacnv- , Cvac , Gsk-plc-adr , Gsk

Dow ekes out new record close, Nasdaq ends lower to start 2024

U.S. stocks end mostly lower Tuesday as investors take profits — and a step back — after a 2023 rally that left the S&P 500 index just shy of a fresh...

Nasdaq , Dow-jones , Dow-jones-industrial-average , Nasdaq-composite , Article-normal , Computers-consumer-electronics , Textiles , Clothing-textiles , Consumer-goods , Financial-services , Investing-securities

S&P 500 Futures Drop in Premarket Trading; Flex Ltd, Marathon Digital Lag

With U.S. stock markets set to open in two hours, (PSTG) was up 5.6% in pre-market trading, and (MKTX) was up 1.8%. (MRNA), (INGR), and (PBF) were all...

Ingredion-inc , Energy-inc , Moderna-inc , Pure-storage-inc , Marathon-digital-holdings-inc , Marketaxess-holdings-inc , Pure-storage , Marketaxess-holdings , Marathon-digital-holdings , Article-normal , Energy

Moderna's stock soars after Oppenheimer upgrades to buy

Moderna's stock started the year with a bang thanks to an analyst upgrade.

Hartaj-singh , Bloomberg , Oppenheimer-co , Bristol-myers-squibb-co , Merck-co , Moderna-inc , Pfizer-inc , Myers-squibb , Article-normal , Biotechnology-services , Pharmaceuticals , Vaccines

Moderna's stock soars after Oppenheimer upgrades to buy

Moderna's stock started the year with a bang thanks to an analyst upgrade.

Hartaj-singh , Bristol-myers-squibb-co , Pfizer-inc , Bloomberg , Oppenheimer-co , Moderna-inc , Merck-co , Myers-squibb , Article-normal , Biotechnology-services , Pharmaceuticals , Vaccines

Picking Through The Rubble Of This Year's Hardest-Hit Stocks

As the end of the year approaches, I like to sift through the debris of the year's biggest stock-market disasters, to see if I can find some bargains. Usually I can find one or two.

Philadelphia , Pennsylvania , United-states , Argentina , California , New-york , Fremont , Brazil , Lucid-group-inc , Icahn-enterprises , Ubiquiti-inc